Status
Conditions
Treatments
About
Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
Full description
Patients included in the registry will be contacted by telephone at 3,6,9, 12 months and 2, 5, 10 years after the procedure. In case coronary slow flow is shown at the index procedure, 39ml of blood will be drawn for further studies.
According to the regulations of the Province Rheinland-Pfalz, national law, and with the approval of the Ethic commission of the Landesärztekammer Rheinland Pfalz, patients (n=1000) will also be retrospectively entered in the database in an anonymous way. For these patients, no specific study procedure is foreseen and the MICAT database will be only used as a platform (database of anonymous data collected during routine clinical practice).
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 1 patient group
Loading...
Central trial contact
Tommaso Gori, PhD, Dott medicina e Chirurgia
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal